Efficacy and Prognostic Factors for PARP Inhibitors in Patients With Ovarian Cancer

Background: The prognostic factors for efficacy of poly(ADP-ribose) polymerase (PARP) inhibitors in ovarian cancer remain unknown. The purpose of this study is to evaluate the efficacy of PARP inhibitors and to explore their prognostic factors in ovarian cancer. Methods: PubMed, Embase, and conferen...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Xuan-zhang, Jia, Han, Xiao, Qiong, Li, Run-zhou, Wang, Xing-shuang, Yin, Hai-yan, Zhou, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308557/
https://www.ncbi.nlm.nih.gov/pubmed/32612955
http://dx.doi.org/10.3389/fonc.2020.00958

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308557/
https://www.ncbi.nlm.nih.gov/pubmed/32612955
http://dx.doi.org/10.3389/fonc.2020.00958

Ejemplares similares